Median Ali, MD
Critical Care Medicine · Kettering, OHNPI 1649253113
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,000 of the $8,501 with a category attached, or 82.3%. Intuitive Surgical accounts for 97.6% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $4,596, more than ten times the $20 reported in 2022. Among critical care medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 21 payments — averaging $404.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- GSK$74
- Pulmonx Corporation$30
- Boehringer Ingelheim$30
- Shionogi Inc$20
- Philips North America LLC$19
- plus $29 from 2 others
What the payments were for
- Travel & lodging$1,28115%
- Food & beverage$2203%
- Education$7,00082%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $8,298 |
| GSK | 4 | $74 |
| Pulmonx Corporation | 1 | $30 |
| Boehringer Ingelheim | 2 | $30 |
| Shionogi Inc | 1 | $20 |
| Philips North America LLC | 1 | $19 |
| United Therapeutics Corporation | 1 | $15 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,251
How this compares
$8,501 in reported general payments places this provider in the 95th percentile of 285 critical care medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 596 | $468,271 |
| OfevNintedanib Esylate | 14 | $169,145 |
| Breo ElliptaFluticasone/Vilanterol | 230 | $100,852 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 113 | $60,756 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 82 | $59,937 |
| Spiriva RespimatTiotropium Bromide | 54 | $37,293 |
| Advair HfaFluticasone Propion/Salmeterol | 45 | $23,702 |
| Spiriva HandihalerTiotropium Bromide | 25 | $20,476 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 34 | $18,789 |
| SymbicortBudesonide/Formoterol Fumarate | 53 | $17,890 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 569 | $11,901 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 93 | $11,596 |
| DuleraMometasone/Formoterol | 17 | $8,800 |
| Incruse ElliptaUmeclidinium Bromide | 21 | $6,976 |
| Wixela InhubFluticasone Propion/Salmeterol | 38 | $5,346 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $74 | $636,856960 claims |
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat | $30 | $225,226102 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $14 | $77,827135 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 285 critical care medicine providers in Ohio.
Other critical care medicine in Kettering
- Jason LeffewKettering$1K
- Neal ChaissonCleveland$428K
- Robert SchilzCleveland$356K
- Nicholas PastisColumbus$145K
- Michael EssandohColumbus$135K
- Chiedozie UdehCleveland$24K
- Kari GorderColumbus$20K
- Elliott CrouserColumbus$16K
- Sadia BenzaquenCincinnati$15K
- Lawrence GoldsteinBoardman$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.